(S)-3-(1H-Indol-3-yl)-2-(4-methylphenylsulfonamido)-N-(4-morpholinophenyl)propanamide

ID: ALA4533418

Chembl Id: CHEMBL4533418

PubChem CID: 137451313

Max Phase: Preclinical

Molecular Formula: C28H30N4O4S

Molecular Weight: 518.64

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1ccc(S(=O)(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)Nc2ccc(N3CCOCC3)cc2)cc1

Standard InChI:  InChI=1S/C28H30N4O4S/c1-20-6-12-24(13-7-20)37(34,35)31-27(18-21-19-29-26-5-3-2-4-25(21)26)28(33)30-22-8-10-23(11-9-22)32-14-16-36-17-15-32/h2-13,19,27,29,31H,14-18H2,1H3,(H,30,33)/t27-/m0/s1

Standard InChI Key:  JEZKLTVUYPYMPE-MHZLTWQESA-N

Alternative Forms

  1. Parent:

    ALA4533418

    ---

Associated Targets(Human)

AIMP2 Tchem Aminoacyl tRNA synthase complex-interacting multifunctional protein 2 (109 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A549 (127892 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 518.64Molecular Weight (Monoisotopic): 518.1988AlogP: 3.84#Rotatable Bonds: 8
Polar Surface Area: 103.53Molecular Species: NEUTRALHBA: 5HBD: 3
#RO5 Violations: 1HBA (Lipinski): 8HBD (Lipinski): 3#RO5 Violations (Lipinski): 1
CX Acidic pKa: 10.36CX Basic pKa: 1.03CX LogP: 4.44CX LogD: 4.44
Aromatic Rings: 4Heavy Atoms: 37QED Weighted: 0.33Np Likeness Score: -1.42

References

1. Sivaraman A, Kim DG, Bhattarai D, Kim M, Lee HY, Lim S, Kong J, Goo JI, Shim S, Lee S, Suh YG, Choi Y, Kim S, Lee K..  (2020)  Synthesis and Structure-Activity Relationships of Arylsulfonamides as AIMP2-DX2 Inhibitors for the Development of a Novel Anticancer Therapy.,  63  (10): [PMID:32315177] [10.1021/acs.jmedchem.9b01961]

Source